Patents by Inventor Roberto Solari

Roberto Solari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR CONJUGATED TO AN ANTIBODY
    Publication number: 20260144890
    Abstract: The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker, or a salt thereof, for use in the treatment of cancer in a patient, wherein the cancer is a refractory cancer which shows resistance to treatment with a topoisomerase inhibitor and/or a tubulin inhibitor.
    Type: Application
    Filed: December 23, 2025
    Publication date: May 28, 2026
    Inventors: Francesca ZAMMARCHI, Jonathan TOBIN, Roberto SOLARI
  • Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy
    Patent number: 12599676
    Abstract: The present invention relates to compounds of formula (I) and related aspects.
    Type: Grant
    Filed: March 6, 2025
    Date of Patent: April 14, 2026
    Assignees: MyricX Pharma Limited, Imperial College Innovations Limited
    Inventors: Robin Carr, Roberto Solari, Andrew Simon Bell, Edward William Tate, Roger Bonnert
  • ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR AND ITS USE
    Publication number: 20260083858
    Abstract: The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker, and related uses.
    Type: Application
    Filed: September 8, 2023
    Publication date: March 26, 2026
    Inventors: Robin CARR, Roberto SOLARI, Edward William TATE, Andrew Simon BELL, Roger BONNERT
  • CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20260049075
    Abstract: The present invention relates to compounds of formula (I) and related aspects.
    Type: Application
    Filed: March 6, 2025
    Publication date: February 19, 2026
    Inventors: Robin CARR, Roberto SOLARI, Andrew Simon BELL, Edward William TATE, Roger BONNERT
  • CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20260048136
    Abstract: The present invention relates to compounds of formula (1) and related aspects.
    Type: Application
    Filed: March 6, 2025
    Publication date: February 19, 2026
    Inventors: Robin CARR, Roberto SOLARI, Andrew Simon BELL, Edward William TATE, Roger BONNERT
  • Immunotherapy using modulators of notch signalling
    Publication number: 20060140943
    Abstract: There is provided a use of a modulator of Notch signalling for the preparation of a medicament for treatment of Graft Versus Host Disease (GVHD) and diseases and conditions caused by or associated with transplants such as organ, tissue and/or cell transplants (e.g. bone marrow transplants), wherein the modulator is used to reduce the reactivity of cells of the immune system.
    Type: Application
    Filed: March 3, 2005
    Publication date: June 29, 2006
    Inventors: Brian Champion, Roberto Solari, Margaret Dallman, Jonathan Lamb, Gerard Hoyne, Emmanuel Cyrille Briend